Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$908K Hold
2,507
– – 0.48% 51
2026
Q1
$882K Buy
2,507
+198
+9% +$70.6K 0.44% 53
2025
Q4
$756K Hold
2,309
– – 0.42% 59
2025
Q3
$652K Hold
2,309
– – 0.38% 63
2025
Q2
$645K Hold
2,309
– – 0.4% 54
2025
Q1
$719K Sell
2,309
-25
-1% -$7.38K 0.49% 48
2024
Q4
$608K Hold
2,334
– – 0.39% 64
2024
Q3
$752K Hold
2,334
– – 0.47% 42
2024
Q2
$729K Hold
2,334
– – 0.47% 43
2024
Q1
$664K Hold
2,334
– – 0.4% 54
2023
Q4
$672K Buy
+2,334
New +$636K 0.47% 44

Other funds holding AMGN

Hara Capital's AMGN Position: Q2 2026 in Review

Hara Capital held its Amgen (AMGN) position steady in Q2 2026 at 2,507 shares worth $908K. The position accounts for 0.48% of the portfolio, ranked #51.

Hara Capital first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hara Capital held 2,507 shares of Amgen worth $908K as of Q2 2026.
  • Hara Capital left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.48% of Hara Capital's portfolio in Q2 2026, its #51 holding.
  • Hara Capital first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.